<p>Time–kill curves of (A) cefoxitin and (B) MMV688844 against <i>Mycobacterium abscessus</i>. The bacteria were grown in liquid culture (Middlebrook 7H9 medium) in the presence of the indicated concentrations of cefoxitin or MMV688844.</p
Mycobacterium abscessus has recently emerged as the cause of an increasing number of human infection...
WOS: 000302339200009PubMed ID: 22378556This study used Sensititre RAPMYCO to test the activities of ...
Abstract Objectives Limited treatment options available for Mycobacterium abscessus infections inclu...
<div><p><i>Mycobacterium abscessus</i> is a rapidly growing life-threatening mycobacterium with mult...
Mycobacterium abscessus is a rapidly growing life-threatening mycobacterium with multiple drug-resis...
<p>Scatter plot distribution showing the results of the <i>M</i>. <i>abscessus</i> screening of the ...
OBJECTIVES: This study was conducted to generate basic pharmacodynamic information on the relationsh...
Mycobacterial killing assay is an important method to determine mycobacterial pathogenesis and antim...
Mycobacterium abscessus infections are increasing worldwide. Current drug regimens are largely ineff...
In this study, application of a dual absorbance/fluorescence assay to a chemical library screen iden...
SummaryObjectivesTo separate Mycobacterium abscessus subsp. bolletii from Mycobacterium abscessus su...
Mycobacterium abscessus is a non-tuberculous mycobacterium that causes pulmonary and non-pulmonary i...
Background. The prognosis of Mycobacterium abscessus infections is poor due to the lack of effective...
WHO estimates that more than 700.000 people die every year as a result of drug-resistant infections....
High-throughput screening facilities do not generally support biosafety level 3 organisms such as My...
Mycobacterium abscessus has recently emerged as the cause of an increasing number of human infection...
WOS: 000302339200009PubMed ID: 22378556This study used Sensititre RAPMYCO to test the activities of ...
Abstract Objectives Limited treatment options available for Mycobacterium abscessus infections inclu...
<div><p><i>Mycobacterium abscessus</i> is a rapidly growing life-threatening mycobacterium with mult...
Mycobacterium abscessus is a rapidly growing life-threatening mycobacterium with multiple drug-resis...
<p>Scatter plot distribution showing the results of the <i>M</i>. <i>abscessus</i> screening of the ...
OBJECTIVES: This study was conducted to generate basic pharmacodynamic information on the relationsh...
Mycobacterial killing assay is an important method to determine mycobacterial pathogenesis and antim...
Mycobacterium abscessus infections are increasing worldwide. Current drug regimens are largely ineff...
In this study, application of a dual absorbance/fluorescence assay to a chemical library screen iden...
SummaryObjectivesTo separate Mycobacterium abscessus subsp. bolletii from Mycobacterium abscessus su...
Mycobacterium abscessus is a non-tuberculous mycobacterium that causes pulmonary and non-pulmonary i...
Background. The prognosis of Mycobacterium abscessus infections is poor due to the lack of effective...
WHO estimates that more than 700.000 people die every year as a result of drug-resistant infections....
High-throughput screening facilities do not generally support biosafety level 3 organisms such as My...
Mycobacterium abscessus has recently emerged as the cause of an increasing number of human infection...
WOS: 000302339200009PubMed ID: 22378556This study used Sensititre RAPMYCO to test the activities of ...
Abstract Objectives Limited treatment options available for Mycobacterium abscessus infections inclu...
DOI
Add to ORKG